admin
August 10, 2026 – The Trump administration today released a highly anticipated proposed rule aimed at addressing what it describes as a significant "loophole" in federal food ingredient transparency. This regulatory action, spearheaded by Health Secretary Robert F. Kennedy Jr., aligns with a central tenet of the administration’s "Make America Healthy Again" (MAHA) movement, which advocates for stricter oversight of food additives and a clearer understanding of the American food supply. However, the proposal has been met with immediate criticism from leading consumer and public health advocacy groups, who argue it falls short of truly safeguarding public health by omitting crucial independent safety reviews.
The proposed rule, issued by the Food and Drug Administration (FDA), would mandate that food companies formally notify the agency when introducing a new ingredient via the "generally recognized as safe" (GRAS) pathway. This notification would require companies to submit the scientific basis supporting their claim of safety. While this marks a departure from the current system, where notification is voluntary, critics contend the proposal does not go far enough. Notably absent are provisions for a mandatory, independent review of these ingredients by the FDA or a third party before they enter the market. Furthermore, the rule fails to outline a comprehensive plan for conducting post-market reviews of GRAS ingredients already widely used in consumer products.
The Historical Evolution of the GRAS System: Intent Versus Reality
To understand the current controversy, it is essential to delve into the origins and evolution of the GRAS process. The concept of "generally recognized as safe" was first established by Congress in 1958 as part of the Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act. Its original intent was to exempt common, well-understood substances—such as salt, sugar, vinegar, and paprika—from the rigorous pre-market approval process typically required for new food additives. The rationale was that these substances, based on a history of safe use or scientific consensus among qualified experts, did not necessitate extensive, time-consuming FDA review.
The system was designed with an "expert panel" provision, allowing companies to convene their own panel of qualified scientists to determine if an ingredient was GRAS. If the panel reached a consensus that the substance was indeed safe for its intended use, the company could then introduce it into the food supply without direct FDA scrutiny, beyond a voluntary notification process. This self-certification mechanism was initially seen as a pragmatic approach for substances with an undeniable history of safe consumption.
However, over the decades, the application of the GRAS process began to drift significantly from its original, narrow scope. What began as an exemption for foundational kitchen staples gradually expanded to encompass a vast array of novel chemicals, artificial flavors, preservatives, and processing aids. Companies increasingly utilized the GRAS pathway to introduce new ingredients more rapidly and with less regulatory burden than the full food additive approval process, which can be lengthy and expensive.
The scale of this shift is starkly illustrated by a July 2025 study from the Environmental Working Group (EWG). Their analysis revealed that since the year 2000, an astonishing nearly 99 percent of new food chemicals introduced into the market have bypassed direct FDA review, instead entering the food supply through the industry-led GRAS process. This statistic underscores the profound transformation of the GRAS system from a limited exemption into the primary conduit for new food ingredients.
Decades of Advocacy: The "Secret GRAS Rule" Controversy
For decades, consumer and public health advocacy groups have vociferously campaigned for comprehensive reform of the GRAS process. They have consistently characterized the current system as a "secret loophole" that allows potentially harmful or inadequately tested chemicals to enter the food supply with minimal, if any, independent federal oversight. Organizations like the Center for Science in the Public Interest (CSPI), the Environmental Working Group (EWG), and Consumer Reports have published numerous reports, launched public awareness campaigns, and petitioned the FDA to close what they perceive as a critical gap in food safety regulations.
Their central argument revolves around the inherent conflict of interest when companies are solely responsible for determining the safety of their own products. Without mandatory notification, the FDA itself has often been unaware of substances entering the market, let alone having the opportunity to evaluate their safety. Even with voluntary notification, the agency’s review is often limited to the data provided by the manufacturer, lacking the independent verification or comprehensive risk assessment that a full pre-market approval process would entail.
The "Make America Healthy Again" Movement and RFK Jr.’s Mandate
In recent years, the movement for GRAS reform has gained significant political traction, particularly within the Trump administration’s "Make America Healthy Again" (MAHA) initiative. This movement, championed by Health Secretary Robert F. Kennedy Jr., emphasizes a holistic approach to public health, focusing on the quality of the food supply, environmental factors, and a re-evaluation of current regulatory frameworks. A core pillar of MAHA is enhanced transparency and stricter oversight of food ingredients, with a particular focus on those commonly found in ultra-processed foods.
Secretary Kennedy has made GRAS reform a stated priority since assuming his role. Early in his tenure, in March 2025, he specifically directed the FDA to explore avenues for revising the controversial GRAS food additive rules, signaling the administration’s intent to address the long-standing criticisms. His public statements have consistently highlighted the systemic deficiencies. "Under the current system, the FDA does not even have a complete picture of what is entering the food supply, and neither of course, do the American people," Kennedy remarked at a food-policy celebration on Monday, referencing a public address he gave earlier this week. He attributed this lack of transparency directly to "the way that the GRAS system evolved," underscoring his belief that the system has veered off its intended course.
Dissecting the Proposed Rule: A Step, But Not a Leap
The proposed rule, if finalized, represents a significant procedural change by making notification of new GRAS ingredients mandatory rather than voluntary. This shift is intended to give the FDA a more complete inventory of substances being added to foods. Companies would be required to submit their safety assessment and supporting data to the agency, providing a baseline of information that the FDA currently lacks for many GRAS substances.
However, the specific criticisms from public health advocates highlight what they consider to be the proposal’s critical shortcomings. The absence of a mandatory independent review before market entry remains the primary concern. Under the proposed rule, a company could still submit its notification and supporting data, and then proceed to market its product containing the new GRAS ingredient without explicit FDA approval or an independent evaluation of the submitted safety data. This means that the burden of proving harm would still largely fall on the FDA or external watchdogs after a product has reached consumers, rather than ensuring safety before exposure.
Furthermore, the proposal does not address the vast number of GRAS ingredients already in the food supply, many of which were introduced through the voluntary notification process or even without any notification at all. A plan for systematically reviewing these existing ingredients, which have been part of the American diet for years, is conspicuously absent.
Advocates Speak Out: "Lacks Substance" and "Loophole Ajar"
The immediate reactions from key advocacy groups underscore the deep dissatisfaction with the proposed rule’s scope. Melanie Benesh, vice president of government affairs at the Environmental Working Group, issued a statement emphasizing the need for further strengthening. "The reforms should include independent safety reviews before an ingredient hits the market, along with a plan for addressing GRAS substances already in products on the market," Benesh stated, reiterating EWG’s long-held positions on comprehensive GRAS reform. EWG has been at the forefront of identifying problematic chemicals in food and advocating for stronger federal oversight, often highlighting substances that, despite being GRAS, have raised scientific concerns.
Peter Lurie, president of the Center for Science in the Public Interest (CSPI), was equally critical, stating that the proposal "will need to be strengthened and finalized before it can have a substantial impact." Lurie specifically pointed out that the rule would still permit companies to sell products both before and during the process of submitting a GRAS notice, effectively maintaining the status quo regarding pre-market approval. "There’s no requirement for products to get approval from the FDA before going to market," he stressed in a statement, calling into question the true impact of the proposed changes on consumer safety. CSPI has a long history of challenging the GRAS system, including legal actions and detailed reports exposing its deficiencies.
Adding to the chorus of disappointment, Brian Ronholm, director of food policy at Consumer Reports, expressed profound skepticism. "Considering the out-of-control, self-regulatory system we currently have for food ingredients, it’s disappointing that today’s announcement lacks substance and doesn’t propose anything meaningful," Ronholm commented. Consumer Reports, known for its rigorous product testing and advocacy for consumer rights, echoed the sentiment that the administration’s proposal represents a missed opportunity for impactful reform.
Implications of an Unreformed System
The ongoing debate surrounding the GRAS process carries significant implications for public health, consumer trust, and the regulatory landscape. If the system remains largely self-regulatory, the potential for untested or inadequately reviewed ingredients to enter the food supply persists. This raises concerns about long-term health effects that may not manifest immediately, such as chronic diseases, allergic reactions, or developmental issues. The lack of independent pre-market review means that consumers effectively become the unwitting test subjects for new chemicals.
Furthermore, the current system erodes public trust in food safety. When consumers learn that a vast majority of new ingredients bypass direct government approval, it can foster cynicism about regulatory effectiveness and increase anxiety about the safety of everyday food products. This lack of transparency also makes it incredibly difficult for researchers, public health officials, and even the FDA itself to comprehensively track and assess the cumulative impact of various food additives on the population.
From an economic perspective, while industry often argues that the GRAS process fosters innovation and efficient market entry, critics counter that this efficiency comes at the potential cost of public health. A more robust, transparent system with independent review, they argue, would create a level playing field, reward genuinely safe innovation, and ultimately lead to a healthier population, reducing long-term healthcare burdens.
The Public Comment Period: A Critical Juncture
The proposed rule is now open for public comment, providing a crucial opportunity for stakeholders—including consumer advocates, industry representatives, scientists, and individual citizens—to submit their feedback to the FDA. This period, typically lasting 60 to 90 days, allows the agency to gather diverse perspectives and scientific data that can inform the final version of the rule. Advocates are expected to mobilize extensively during this period, urging the FDA to incorporate their recommendations for mandatory independent review and a plan for existing GRAS substances. The nature and volume of these comments will play a significant role in shaping whether the final rule is strengthened or remains largely consistent with the current proposal.
Beyond GRAS: The Push to Define Ultra-Processed Foods
The proposed GRAS rule is not the only food policy initiative under the MAHA umbrella. During Monday’s food-policy celebration, Secretary Kennedy also highlighted significant progress in another key MAHA pillar: defining "ultra-processed foods" (UPFs). The consumption of these foods remains notably high across the American diet, as highlighted by a CDC report in August 2025, underscoring the urgency of this initiative. Creating a formal, federal definition for UPFs is seen as a vital step toward enhancing transparency in the food system, enabling clearer labeling, facilitating public health research, and potentially guiding future dietary guidelines and policy interventions.
This interagency process involves the Department of Health and Human Services (HHS), the FDA, and the U.S. Department of Agriculture (USDA), reflecting the broad impact of UPFs on public health, food production, and consumer behavior. Just last week, the proposed definition was forwarded to the Office of Management and Budget (OMB) for its final review, indicating it is nearing official publication. However, the exact timeline for its public release remains uncertain. The MAHA movement views the reform of the GRAS system and the definition of ultra-processed foods as complementary efforts, both aimed at providing Americans with a clearer understanding of what they consume and empowering healthier dietary choices. Many of the ingredients introduced via the GRAS pathway ultimately find their way into ultra-processed products, creating a direct link between the two policy areas.
Looking Ahead: The Future of Food Safety Regulation
The unveiling of this proposed GRAS rule marks a significant moment in the ongoing national conversation about food safety and regulatory oversight. While it signals a move toward greater transparency, the debate over its sufficiency highlights the persistent tension between industry’s desire for efficient innovation and public health advocates’ demand for robust, independent safety assurance.
The public comment period will be critical in determining the final shape of the rule. The outcome will not only influence the safety of new food ingredients but also set a precedent for future regulatory actions in an increasingly complex food environment. As scientific understanding of food chemistry and its effects on human health continues to evolve, the challenge for regulators will be to strike a balance that fosters innovation while unequivocally prioritizing the health and trust of the American consumer. The path forward for food additive safety remains a contested terrain, with advocates determined to ensure that "generally recognized as safe" truly means safe, not just self-certified.
